Clinical Trial

Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil

Study acronym: MADONNA
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 7, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
An evaluation of the molecular and epidemiological aspects of endometrial cancer in Brazil is necessary to understand the high frequency of advanced disease. A better understanding of the current situation will generate essential data for the future development of national or international cooperative programs that aim to improve outcomes in these patients and generate additional knowledge for much-needed clinical trials in this population.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-08-23; most recent amendment 2025-03-06.
Status change: Recruiting → Active, Not Recruiting 2025-03-06
Status change: Not Yet Recruiting → Recruiting 2023-11-09
Trial Details
NCT Number NCT06014580
Lead Sponsor Latin American Cooperative Oncology Group
Collaborators: GlaxoSmithKline
Conditions Endometrial Cancer
Enrollment 276 participants
Start Date 2023-11-27
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-07